A retrospective observational cohort study comparing the medication adherence and persistence of once-daily inhaled corticosteroid/long-acting β2-agonist Fluticasone-furoate/Vilanterol versus the twice-daily Budesonide/Formoterol and Fluticasone propionate/Salmeterol among patients with Asthma
Latest Information Update: 18 Jul 2023
At a glance
- Drugs Budesonide/formoterol (Primary) ; Salmeterol/fluticasone propionate (Primary) ; Vilanterol/fluticasone furoate (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 29 Sep 2021 New trial record